Vanesa Pytel
Overview
Explore the profile of Vanesa Pytel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
582
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moral-Rubio C, Suarez-Coalla P, Fernandez-Romero L, Perez-Izquierdo C, Delgado-Alvarez A, Delgado-Alonso C, et al.
J Alzheimers Dis
. 2025 Feb;
:13872877251315182.
PMID: 39994984
Background: Non-invasive brain stimulation has shown positive results in maximizing the effects of language therapy in primary progressive aphasia (PPA). Due to the different patterns of brain damage in each...
2.
Rosende-Roca M, Garcia-Gutierrez F, Cantero-Fortiz Y, Alegret M, Pytel V, Canabate P, et al.
Alzheimers Res Ther
. 2025 Jan;
17(1):27.
PMID: 39844303
Background: Alzheimer's disease (AD) stands as the leading cause of dementia worldwide, and projections estimate over 150 million patients by 2050. AD prevalence is notably higher in women, nearly twice...
3.
Morato X, Puerta R, Cano A, Orellana A, de Rojas I, Capdevila M, et al.
Brain Behav Immun Health
. 2024 Dec;
42:100899.
PMID: 39640195
Despite the central role attributed to neuroinflammation in the etiology and pathobiology of Alzheimer's disease (AD), the direct link between levels of inflammatory mediators in blood and cerebrospinal fluid (CSF)...
4.
Morato X, Tartari J, Pytel V, Boada M
J Alzheimers Dis
. 2024 Oct;
101(s1):S285-S298.
PMID: 39422946
Extracts made from plants are complex mixtures of substances with varying compositions depending on the plant material and method of manufacture. This complexity makes it difficult for scientists and clinicians...
5.
Puerta R, de Rojas I, Garcia-Gonzalez P, Olive C, Sotolongo-Grau O, Garcia-Sanchez A, et al.
medRxiv
. 2024 Sep;
PMID: 39281766
Background: Alzheimer's disease (AD) has a high heritable component characteristic of complex diseases, yet many of the genetic risk factors remain unknown. We combined genome-wide association studies (GWAS) on amyloid...
6.
Debette S, Caro I, Western D, Namba S, Sun N, Kawaguchi S, et al.
Res Sq
. 2024 Jul;
PMID: 39011113
Cerebral small vessel disease (cSVD) is a leading cause of stroke and dementia with no specific mechanism-based treatment. We used Mendelian randomization to combine a unique cerebrospinal fluid (CSF) and...
7.
Garcia-Sanchez A, Sotolongo-Grau O, Tartari J, Sanabria A, Esteban-De Antonio E, Perez-Cordon A, et al.
Alzheimers Res Ther
. 2024 Feb;
16(1):42.
PMID: 38378643
Introduction: Optical coherence tomography angiography (OCT-A) is a novel tool that allows the detection of retinal vascular changes. We investigated the association of macular vessel density (VD) in the superficial...
8.
Saez M, Garcia-Sanchez A, de Rojas I, Alarcon-Martin E, Martinez J, Cano A, et al.
Alzheimers Res Ther
. 2024 Feb;
16(1):38.
PMID: 38365752
Background: Several studies have reported a relationship between retinal thickness and dementia. Therefore, optical coherence tomography (OCT) has been proposed as an early diagnosis method for Alzheimer's disease (AD). In...
9.
Garcia-Gutierrez F, Alegret M, Marquie M, Munoz N, Ortega G, Cano A, et al.
Alzheimers Res Ther
. 2024 Feb;
16(1):26.
PMID: 38308366
Background: Advancement in screening tools accessible to the general population for the early detection of Alzheimer's disease (AD) and prediction of its progression is essential for achieving timely therapeutic interventions...
10.
Frederiksen K, Morato X, Zetterberg H, Gauthier S, Boada M, Pytel V, et al.
Alzheimer Dis Assoc Disord
. 2024 Feb;
38(1):1-7.
PMID: 38300883
Background: Despite the number of people living with Alzheimer disease (AD), awareness of the early stages of this condition, including mild cognitive impairment due to AD-which poses management challenges-continues to...